MERIT MEDICAL SYSTEMS INC (MMSI) FY2026 Q2 P&L / Income Statement

MERIT MEDICAL SYSTEMS INC (MMSI) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

418,843,000 US dollars

Cost of sales

203,677,000 US dollars

Gross profit

215,166,000 US dollars

Total operating expenses

154,763,000 US dollars

Income from operations

60,403,000 US dollars

Total other (expense) income - net

negative 9,089,000 US dollars

Income before income taxes

51,314,000 US dollars

Income tax expense

12,511,000 US dollars

Net income

38,803,000 US dollars

Access

161,786,000 US dollars

Foundational, Original Equipment Manufacturer

48,338,000 US dollars

Procedural Solutions

27,949,000 US dollars

Vascular Intervention

41,652,000 US dollars

Other

1,236,000 US dollars

Cardiac Therapies

28,510,000 US dollars

Endoscopy

23,647,000 US dollars

Therapeutic, Original Equipment Manufacturer

12,797,000 US dollars

Oncology

25,774,000 US dollars

Renal Therapies

12,713,000 US dollars

Vascular Intervention

34,441,000 US dollars

Selling, general and administrative

129,229,000 US dollars

Research and development

25,389,000 US dollars

Contingent consideration expense (benefit)

145,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.